March 2016 FDA Recall Drug by Hospira Inc.
D-0854-2016 - Failed pH Specifications

This Class III drug recall was voluntarily initiated by Hospira Inc. on March 23, 2016 for the product Drug. The FDA reported the reason for recall as failed ph specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0854-2016

Reason for Recall
Failed pH Specifications: Confirmed high out of specification (OOS) results for pH.
Initiated
03-23-2016
Reported
05-25-2016
Quantity
715,200 vials

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Nationwide, Puerto Rico, United Arab Emirates, Israel, Kuwait, Bahrain, and Trinidad & Tobago
Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2168-02, barcode (01) 2 030409 216802 5.

Batch or Lot Expiration Information

Lot# : 42-335-DK, Exp 1JUN2016; 48-128-DK, 48-129-DK, 48-261-DK, 48-262-DK, 48-351-DK, Exp 1DEC2016; 52-361-DK, Exp 1APR2017; note that the lot number may be followed by numbers from 01 to 99.